Mirum Therapeutics acquired two bile disorder drug products from Travere Therapeutics. Credit: peakSTOCK via Getty Images. California-based biotech Mirum Therapeutics has announced the completion of
VANCOUVER, British Columbia, Sept. 06, 2023 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage pharmaceutical
Researchers examined the cell-intrinsic effects of hematopoietic stem cells with somatic mutations in circulating cells from heart failure patients.
Researchers reviewed the evidence for SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).
Researchers assessed ChatGPT’s ability to address the 50 most common misconceptions about vaccine safety.
Researchers used a SARS-CoV-2 spike protein-pseudotyped viral model to characterize BA.2.86 variant neutralization by monoclonal antibodies.
AstraZeneca has spoken about how they are delivering ambitious plans to help other pharma companies follow suit. Image credit: AstraZeneca. AstraZeneca has big plans to
Seven months after Nimbus Therapeutics sold an experimental autoimmune disease medicine to Takeda Pharmaceuticals for up to $6 billion, the Boston biotech said Wednesday it has raised
Top of the morning to you. And a steamy one, it is. In fact, there is more steam rising from the grounds of the Pharmalot
TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a commercial-focused specialty pharmaceutical company, is pleased